Special Topix™: Multi-Specialty Impact of COVID-19 (US)
Special Topix™: Multi-Specialty Impact of COVID-19 (US) is an ongoing series of monitoring evaluating the impact of COVID-19 on physicians and their practices – including, but not limited to, the utilization of telemedicine, at-risk patient groups, key concerns, support from industry, future changes in prescribing patterns, how practices are beginning to re-open, and what changes have been implemented as the new normal.
Specialty reports are available for dermatology, gastroenterology, nephrology, neurology, and rheumatology. Each wave consists of feedback gathered from 250 specialists (~50 per specialty), geographically dispersed across the US. The report is offered by specialty and includes high-level cross-specialty comparisons trended since mid-March. Waves 12 and 13 are set to publish in November and December.